Accu Reference Medical Lab

Accu Reference Medical Lab, founded in 2005, is a key player in Medical Testing & Clinical Laboratories and Healthcare. The company specializes in diverse diagnostic testing, including non-invasive liver disease tests, tick-borne disease diagnostics, and gastrointestinal pathogen panels. They provide advanced solutions like the Prostate Health Index and UTI molecular tests, aiding healthcare providers and patients in early detection and management of health conditions. Their commitment is to deliver quick, accurate results via state-of-the-art laboratory services to U.S. physicians, providers, and patients.

Operating across 58 locations with 500-1,000 employees, Accu Reference Medical Lab possesses substantial operational scale. This enables efficient delivery of diagnostic and laboratory services, encompassing advanced screening, microbiology, and specialty testing, including ob/gyn diagnostics. The company's core mission revolves around delivering rapid, precise results to support clinical decision-making and enhance patient care. Understanding the team driving these operations is possible by accessing Meet Accu Reference Medical Lab's team.

Financially, Accu Reference Medical Lab reports a revenue of $115.3M. In April 2020, the company received $5M in debt funding from PPP. It operates in a competitive market alongside entities such as Clinical Labs and CompuNet Clinical Laboratories. Their product offerings span various diagnostic tests, laboratory services, and screening solutions, underscoring their role in healthcare diagnostics. Detailed financial performance and metrics can be explored through Explore financial highlights.